← Leaderboards
Evripidis Gavathiotis
Albert Einstein College Of Medicine
$9,805,575
Attributed
$13,355,792
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,355,792 · 7
By mechanism
R01$10,631,926 · 3
P01$1,872,365 · 2
R00$715,961 · 1
K99$135,540 · 1
Top collaborators
- Sergio Daniel Catz10 shared
- Stephanie Cherqui10 shared
- Ana M. Cuervo9 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Onyinyechukwu Chioma Uchime$144,372
- Rui Chang$4,628,013
- Yvonne Margaret Saenger$3,946,350
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoPathway InteractionsMediatingPharmaceutical ChemistryRegulationLeadSmall MoleculeBiochemicalInsightCell DeathApoptosisPropertyProteinsCellsInnovationAutophagocytosisMitochondriaMolecularMutantDrug KineticsCessation Of LifePathogenesisAlzheimer&AposMutation
Grant awards (35)
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$740,732
R01 · FY2025 · DK
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$715,764
R01 · FY2024 · DK
Allosteric inhibitors targeting oncogenic BRAF V600E dimers$428,455
R01 · FY2024 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$379,052
R01 · FY2024 · CA · contact PI
Core D - Chemical Biology and Therapeutics Innovation Core$374,641
P01 · FY2024 · AG · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$109,451
R01 · FY2024 · DK
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$725,337
R01 · FY2023 · DK
Allosteric inhibitors targeting oncogenic BRAF V600E dimers$441,985
R01 · FY2023 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$391,020
R01 · FY2023 · CA · contact PI
Core D - Chemical Biology and Therapeutics Innovation Core$374,640
P01 · FY2023 · AG · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$107,666
R01 · FY2023 · DK
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$725,337
R01 · FY2022 · DK
Allosteric inhibitors targeting oncogenic BRAF V600E dimers$441,985
R01 · FY2022 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$391,020
R01 · FY2022 · CA · contact PI
Core D - Chemical Biology and Therapeutics Innovation Core$374,640
P01 · FY2022 · AG · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$786,695
R01 · FY2021 · DK
Allosteric inhibitors targeting oncogenic BRAF V600E dimers$447,702
R01 · FY2021 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$399,000
R01 · FY2021 · CA · contact PI
Core D - Chemical Biology and Therapeutics Innovation Core$374,640
P01 · FY2021 · AG · contact PI
Allosteric inhibitors targeting oncogenic BRAF V600E dimers$435,189
R01 · FY2020 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$398,307
R01 · FY2020 · CA · contact PI
Core D - Chemical Biology and Therapeutics Innovation Core$373,804
P01 · FY2020 · AG · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$269,382
R01 · FY2019 · DK
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$331,066
R01 · FY2018 · CA · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$274,972
R01 · FY2018 · DK
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$15,459
R01 · FY2018 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$346,525
R01 · FY2017 · CA · contact PI
Molecular and Cellular Mechanisms of the Lysosomal Storage Disease Cystinosis$290,250
R01 · FY2017 · DK
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$346,525
R01 · FY2016 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$346,525
R01 · FY2015 · CA · contact PI
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy$346,525
R01 · FY2014 · CA · contact PI
Targeting BAX Oligomerization in Hematologic Disease$224,470
R00 · FY2013 · HL · contact PI
Targeting BAX Oligomerization in Hematologic Disease$242,491
R00 · FY2012 · HL · contact PI
Targeting BAX Oligomerization in Hematologic Disease$249,000
R00 · FY2011 · HL · contact PI
Targeting BAX Oligomerization in Hematologic Disease$135,540
K99 · FY2010 · HL · contact PI